Why well-qualified medical school graduates can’t get jobs — despite doctor shortages

“despite the great need for more doctors, there are still huge gaps between the number of aspiring physicians and the space available to train them, a dynamic that keeps perfectly well-qualified medical school applicants and graduates out of the pipeline.

In 2021, for instance, there were a record-setting 42,508 active applicants for residency programs — 3,741 more than in 2020 — but only 35,194 first-year positions, according to the National Resident Matching Program. Although the number of residency spots has been creeping upward in recent years, the growth has not been fast enough to close the gap.

At the root of the mismatch between physician supply and demand are decades-old limits on medical school enrollment and outdated rules governing the federal funding for most residency programs. While Congress has taken some baby steps toward increasing that funding, it has yet to make the kinds of bold changes necessary to create a sustainable and pandemic-resilient physician workforce.”

“The US medical system falls behind those of our peer countries in so many ways. We have higher administrative costs and worse outcomes than other high-income countries — and we also have fewer physicians available per person.

“If you take a look at EU countries that have sophisticated medical systems,” explained Janis Orlowski, chief health care officer at the AAMC, “they have between 30 and 40 physicians per 10,000 people. In the United States, we have about 26 to 27.”

It’s not an apples-to-apples comparison, in part because physicians use their time differently in different systems. But it’s clear the shortage is a burden, and it’s likely to get worse as the US population grows larger and older.”

“In a December 2021 survey conducted by the American Medical Association, one in five physicians said they would likely leave their current practice within two years, and about a third said they’d likely reduce their work hours in the next year.

The larger workforce trend has been dubbed the “Great Resignation,” and the reasons doctors are quitting echo the factors contributing to shortfalls among other health professionals, including nurses, medical assistants, physical therapists, and pharmacists. Burnout, fear of exposure, pandemic-related mood changes, and workload were all associated with intent to leave the profession.”

“It’s easy to imagine a simple solution for this problem: Incentivizing doctors from other countries to immigrate to the US. But this is not as quick a fix as it seems. Most states require doctors to complete residency training in the US, which takes at least three years. That applies even for doctors who practiced independently at expert levels in other countries; the chief of surgery at the fanciest hospital in India would still have to repeat residency in order to practice in the US.

About 13,000 of the residency match applicants this year were graduates of international medical schools, 8,000 of whom were not US citizens. But no matter how many additional doctors want to jump through the hoops necessary to practice in the US, long waits for visas and restrictive terms limiting where and for how long they can practice in the US make it unlikely many more will be added to the health care workforce in the near term.”

“One major bottleneck in the physician pipeline is medical school admissions, which are only graduating about 27,000 students each year. “That started in the 1980s with the freakout over a physician surplus,” said Robert Orr, a social policy analyst at the Niskanen Center in Washington, DC. At the time, miscalculations about population growth and changes in medical care delivery contributed to a moratorium on medical school enrollment that lasted until 2005.

Although medical schools have since continued to grow, expanding too quickly could result in a surplus of medical graduates with nowhere to do their residencies. That’s because of the other major bottleneck in the pipeline — the low number of residency positions. This year’s 36,000 first-year residency slots are inadequate to meet the US need for physicians and inadequate to provide training positions for all the applicants seeking them — and like the dearth of medical school seats, it is a consequence of restrictions created long ago with arguably good intentions.

Since the Medicare and Medicaid Act was first passed in 1965, medical residents have been paid for mostly by the Medicare and Medicaid programs. The goal was to ensure Medicare beneficiaries had access to the best health care, which was thought to be found in teaching hospitals.

In 1983, Medicare made changes to the way it reimbursed hospitals for residency programs. At that time, it created formulas that calculated the dollar amount of residency training funds it supplied to each hospital as a percentage of that hospital’s care expenditures and its volume of Medicare patients — sort of like a restaurant tip, said Orr.

Those formulas have never been updated — and because they tie funding to the cost of care, they have resulted in better funding for hospitals providing high-cost care in high-cost (usually urban) areas.

Over the years, this inequitable distribution of residency program funding has meant that hospitals prioritizing primary care services in rural areas get less funding and fewer residents than those that perform lots of expensive procedures in cities. That leads to fewer primary care specialists, and because physicians often practice near where they train, fewer rural physicians.

This fee structure also incentivizes hospitals to raise the cost of the care they deliver, and results in lower funding for residency programs at hospitals that treat younger populations less likely to be covered by Medicare.

Worse yet, to reduce Medicare expenditures, the Balanced Budget Act of 1997 capped the number of resident slots that could be funded by Medicare each year. It also capped the number of residents each hospital could have at their 1996 levels, which meant hospitals couldn’t get additional residents even if the population they served ballooned in size. Obamacare undid this restriction in 2010, and since then, the number of residency spots has grown modestly.

In 2020, Congress passed a federal budget bill that provided for 1,000 new Medicare-funded residency slots to be added over the next five years. But that’s nowhere near enough to close the current gaps.

Money donated by private insurers funds some residency positions at “the hospitals with the prestige and market power to extract it,” said Orr, but “it’s not a super-equitable way of trying to get residents out to different hospitals where maybe the population isn’t as well served.””

“There are also some solutions that sidestep the residency bottleneck entirely. One of the more promising fixes to the physician shortage is to allow other highly trained providers, like nurse practitioners, physician assistants, and pharmacists, to practice independently of doctors. The American Medical Association has vigorously fought this change for more than 30 years, and physicians who oppose the move often cite patient safety concerns, although they are not substantiated by safety studies.

Much of the real motivation to prevent these providers from practicing independently may be about money and professional sovereignty; private practice doctors in particular are financially disincentivized from expanding the scope of other practitioners.”

They warned about pandemics before Covid-19. Now they have a $100 billion plan to stop the next one.

“Among other priorities, the plan includes funding for: creating vaccine candidates for each of the 26 families of viruses known to infect humans; developing antiviral medications that can work against a broad spectrum of viruses; building out manufacturing capacity for vaccines, antivirals, tests, and other countermeasures; deploying genomic sequencing as a way to track outbreaks; developing broadly useful diagnostic technologies and better regulatory processes for approving and disseminating plentiful rapid tests; and improving security in laboratories dealing with dangerous viruses.

The White House, to its credit, has already proposed funding around this level. Most recently, in its 2023 budget proposal, the Biden administration asked for $88.2 billion in funding over five years on pandemic preparedness. That includes $40 billion for the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the Department of Health and Human Services to “invest in advanced development and manufacturing of countermeasures for high priority threats and viral families, including vaccines, therapeutics, diagnostics, and personal protective equipment (PPE),” as well as $12.1 billion in research funding for the National Institutes of Health for vaccine, therapeutics, and diagnostics development.

Bumb notes that the Biden proposal actually drew on the original Apollo plan put out by the bipartisan commission. That’s part of why the new commission report is so notable: This is a group that’s capable of driving policymaking at high levels.

That said, Congress has yet to appropriate money at the commission’s desired level to prevent the next pandemic. It’s barely interested in further funding response to the current, ongoing pandemic, which is still killing hundreds of Americans a day. A group of senators recently cut a deal for $10 billion to fund Covid-19 response, after slashing funding the White House wanted to help fight the pandemic abroad — only to have Republicans block the deal on the Senate floor over separate immigration concerns. Even if the funding eventually passes, it’ll have to wait until after the Easter recess ends on April 22.”

The hidden epidemic

“the overuse of antibiotics, whether in human patients or in livestock, results in bacteria adapting to the drugs, leading them to become less effective over time. If the pace of resistance isn’t halted — whether through more judicious use of the drugs or through the development of new classes of antibiotics — it will likely lead to soaring deaths from common infections and surgical complications, sending us back to a world where a minor cut could potentially once again be lethal.

We can avoid this fate, but it will require coordinating a global response before it’s too late.”

We’ll never have a normal flu season again

“Before the pandemic, the flu alone could sometimes push hospital systems into crisis mode, where they cancel elective procedures and limit other kinds of care. Now there’s Covid-19, which has done the same thing on its own.

Suddenly conjuring more hospital capacity every winter to handle the expected surges of flu and Covid-19 is not going to happen. Thousands of additional hospital beds are not coming in the next few years, and the US would not have the doctors and nurses to staff them anyway. It will take much longer — years or maybe decades — to improve the gaps in America’s health care infrastructure and workforce that have been exposed during Covid-19.

This means the imperative to “flatten the curve,” to limit the spread of these viruses to stop hospitals from being overwhelmed, will be with us for a long time. But the makeup of the curve will change, measuring multiple diseases instead of one.”

“Vaccination is the best way to stop a bad Covid-and-flu season before it starts.”

“Surveillance is critical, starting with early-warning systems. Public health institutions have long monitored the flu and they are already tracking Covid-19 in a similar manner. Monitoring the amount of virus detected in local wastewater has proven to be a reliable leading indicator of new Covid-19 waves during the pandemic. And widespread, reliable testing will be essential — including at-home tests for both Covid-19 and the flu.”

“Frequent testing lets people know that they should isolate. If they are at higher risk of severe illness, they can get on antivirals quickly. The current therapies are most effective at stopping serious symptoms that could require hospitalization if they are taken within the first few days of an illness. Research in the last decade has found that flu antivirals are too often underprescribed for patients who would benefit most; improving prescription rates is only more critical now that the health system will be contending with both the flu and Covid-19 going forward.”

Congress is on the brink of an immense health policy failure

“The coronavirus pandemic has fully exposed the flaws in the US health care system and deepened many of its disparities. Yet there is a serious possibility, now that Sen. Joe Manchin (D-WV) has rendered the current version of the Build Back Better Act dead, that the current Congress will not pass any long-term provisions to cover more people, make health care more affordable, or better prepare the nation for the next pandemic.

Though they have not attracted as much attention as other parts of the legislation, Democrats had written a wide-ranging health care section in Build Back Better. They were planning to patch up holes in the Affordable Care Act, extending assistance to middle-class families as well as people in poverty; to reduce drug costs for millions of Americans; and to make investments in the country’s health care infrastructure, with the goal of better preparing the US for the inevitable next pandemic.”

Mexico’s ‘Junk Food’ Warning Labels Are Junk

“Mexico’s controversial, year-old, mandatory, front-of-package food warning label law was supposed to help Mexicans make healthier food choices and slash sky-high obesity rates in the country.

The law, which took effect one year ago this week, “requires black informational octagons to be placed on packaged foods that are high in saturated fat, trans fat, sugar, sodium[,] or calories.” Other requirements include that any food which must bear the dreaded black octagon “cannot include children’s characters, animations, cartoons, or images of celebrities, athletes[,] or pets on their packaging.”

Many food producers inside and outside Mexico opposed the labeling law, arguing it’s misleading, burdensome, and paternalistic. The Mexican government, though, claimed the law would lead Mexicans to eat 37 fewer calories per day, which would theoretically result in an average Mexican losing nearly four pounds per year. Some outside Mexico supported the labeling scheme, too. Last year, for example, a World Health Organization (WHO) regional office gushed over the black octagons and gave the Mexican government an award, calling the labels a “public health innovation” that is the “most advanced and comprehensive regulation worldwide.”

But early returns suggest the law’s impact has been negligible at best.

“More than a year after Mexico’s food warning label law took effect, sales of junk food and sugary beverages have not declined significantly, according to a market research firm and a business group,” Mexico News Daily reported last week. “In fact, sales of unhealthy products have increased in some cases, data shows.”

That’s the conclusion of a Mexico-based market research group, Kantar México, which tracks food purchases made by thousands of Mexican households each week. Mexico News Daily also notes that a Mexican government agency says purchases of treats such as candy, chocolates, and soda were higher this past September than they were in September 2020—the same month the WHO rewarded the Mexican government for its purportedly innovative efforts.

Despite the fact the law’s not working as advocates hoped and claimed it would, last week’s Mexico News Daily report notes a Mexican government official praised the labeling scheme as a success because “[c]onsumers are now more informed and empowered to make better choices.””

More And More Americans Are Smoking Pot. What Does That Mean For Their Health?

“Many of pot’s effects are tangled in contradictory research, but there are a few clear health risks to consuming the drug. Smoking cannabis regularly can cause bronchitis-like symptoms, and research published last month found that chronic cannabis users, defined as people who used pot at least four times a week for more than three years, had impaired pancreatic function. There have also been cases of daily cannabis users developing pancreatitis without having any other obvious risk factors.

Regular pot use has also been associated with higher rates of depression, anxiety and poorer life outcomes like being unemployed, but causality has not been established because other factors could predispose someone both to using cannabis and having a mental illness or not having a job.

There’s also evidence that cannabis can be dangerous when used in certain situations, like during pregnancy or while driving a vehicle. A recent study linked increasing rates of childhood leukemia to an increase in cannabis use, and a separate study found a correlation between women using cannabis while pregnant and their children having higher rates of anxiety. There’s also evidence that using pot while pregnant can lead to lower birth weights, although that evidence is still considered limited. And driving a car while high has been shown to moderately increase the risk of getting into a motor vehicle accident.

Addiction can be an issue as well. Some people who smoke pot develop what’s called cannabis use disorder (CUD), a clinical diagnosis of problematic and uncontrollable cannabis use. There’s evidence that CUD rates have increased since 2008, but Dr. Kevin Hill, an addiction psychiatrist and professor at Harvard Medical School, told FiveThirtyEight in an email that “it is still important to point out that most people who use cannabis don’t have a problem with it.”

The 2020 NSDUH found that 4.1 percent of people ages 12-17 met the criteria for CUD,1 13.5 percent of people ages 18 to 25 had the disorder, and 4 percent of people over age 26 had the disorder. Yet those numbers were below rates of alcohol use disorder across all age groups in 2020’s survey.

Deborah Hasin, an epidemiologist at Columbia University, said she is very concerned about adults’ increasing use of cannabis because CUD is associated with poorer quality of life, cognitive decline and impaired educational and occupational employment. Hasin’s research has found that 19.5 percent of people who use cannabis met the criteria of CUD in their lifetimes.

“It’s clear that not everybody who smokes marijuana has all of these problems, but the risk is there, and it’s a greater risk than people assume,” Hasin said.

Using cannabis frequently increases the risks of developing CUD, and frequent pot use is growing among adults. Monthly use for 26-to-34-year-olds has more than doubled since 2008, and the share of people getting at least five days a week increased from 5.8 to 13.8 percent between 2008 and 2019, according to NSDUH survey results.”

“A 2016 study that followed a group of New Zealand adults for 20 years found that cannabis use was associated with worse gum health, but better cholesterol levels, lower BMI and reduced waist circumference.

Those results were further substantiated in a 2020 study that looked at cannabis use among people over the age of 60. Cannabis users in the study exercised more often and had a significantly lower BMI than non-users.

While there’s evidence that BMI, which measures only weight and height, is not the best way to gauge health for people who are normal weight or are slightly overweight, very high BMI scores are significantly associated with mortality.”

The US is about to make the same pandemic preparedness mistakes — again

“Outside experts have estimated that as much as $75 billion should be spent over 10 years on public health infrastructure, preparedness, and prevention.

The revised Build Back Better legislation totals roughly $10 billion in public health infrastructure and pandemic preparedness funding over the next few years — a down payment on better readiness, in Democrats’ view, but one without assurance of future installations.

“All too often, when there’s a crisis, the reaction is to put money into public health. Once the crisis subsides, the funding tends to dry up,” Ron Bialek, president of the Public Health Foundation, told me. “This is not a recipe for success.””